Potential Safety Issues with Medications
The FDA released it's January - March 2008 report with a list of medications with potential signals of serious risks and new safety information identified during this period. I recognize several of the medications, though thankfully they aren't any I take. Though I am sure we all know somebody who takes at least one of these. Check out the list and make sure:
Arginine Hydrochloride Injection (R-Gene 10) -Pediatric overdose due to labeling / packaging confusion
Desflurane (Suprane) - Cardiac arrest
Duloxetine (Cymbalta) - Urinary retention
Etravirine (Intelence) - Hemarthrosis
Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric) - Adverse events due to name confusion
Heparin - Anaphylactic-type reactions
Icodextrin (Extraneal) - Hypoglycemia
Insulin U-500 (Humulin R) - Dosing confusion
Ivermectin (Stromectol) and Warfarin - Drug interaction
Lapatinib (Tykerb) - Hepatotoxicity
Lenalidomide (Revlimid) - Stevens Johnson Syndrome
Natalizumab (Tysabri) - Skin melanomas
Nitroglycerin (Nitrostat) - Overdose due to labeling confusion
Octreotide Acetate Depot (Sandostatin LAR) - Ileus
Oxycodone Hydrochloride Controlled-Release (Oxycontin) - Drug misuse, abuse and overdose
Perflutren Lipid Microsphere (Definity) - Cardiopulmonary reactions
Phenytoin Injection (Dilantin) - Purple Glove Syndrome
Quetiapine (Seroquel) - Overdose due to sample pack labeling confusion
Telbivudine (Tyzeka) - Peripheral neuropathy
Tumor Necrosis Factor (TNF) Blockers - Cancers in children and young adults
To see the FDA's report at fda.gov, click here.